196 related articles for article (PubMed ID: 2899658)
1. [Management of insulinoma with the somatostatin analog SMS 201-995].
Gilsanz Peral A; Gómez Balaguer M; Costa Talens P
Med Clin (Barc); 1988 Apr; 90(15):634-5. PubMed ID: 2899658
[No Abstract] [Full Text] [Related]
2. [Malignant insulinoma: lack of response to the somatostatin analog SMS 201-955].
Ligorria C; Montaña E; Virgili N
Med Clin (Barc); 1989 Nov; 93(17):676. PubMed ID: 2559266
[No Abstract] [Full Text] [Related]
3. Somatostatin analogs in the management of gastrointestinal tumors.
Lamberts SW
Horm Res; 1988; 29(2-3):118-20. PubMed ID: 2900191
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin analogues in the management of benign insulinomas.
Laron Z
Isr J Med Sci; 1990 Jan; 26(1):1-2. PubMed ID: 2155883
[No Abstract] [Full Text] [Related]
5. [Preoperative treatment of hypoglycemia caused by an insulinoma with the somatostatin analog SMS 201-995].
Sánchez García Cervigón P; Fernández Navarro JI; Salmerón de Diego J; Caballero Asensi A; Cornelio Hernández F; Jara Albarrán A
Med Clin (Barc); 1987 Oct; 89(12):511-3. PubMed ID: 2890800
[No Abstract] [Full Text] [Related]
6. Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome.
Altimari AF; Bhoopalam N; O'Dorsio T; Lange CL; Sandberg L; Prinz RA
Surgery; 1986 Dec; 100(6):989-96. PubMed ID: 2878500
[TBL] [Abstract][Full Text] [Related]
7. Malignant insulinoma: is combined treatment with verapamil and the long-acting somatostatin analogue octreotide (SMS 201-995) more effective than single therapy with either drug?
Stehouwer CD; Lems WF; Fischer HR; Hackeng WH
Neth J Med; 1989 Aug; 35(1-2):86-94. PubMed ID: 2550827
[TBL] [Abstract][Full Text] [Related]
8. Malignant insulinoma: effects of a somatostatin analog (compound 201-995) on serum glucose, growth, and gastro-entero-pancreatic hormones.
Osei K; O'Dorisio TM
Ann Intern Med; 1985 Aug; 103(2):223-5. PubMed ID: 2861769
[No Abstract] [Full Text] [Related]
9. A somatostatin analogue inhibits chondrosarcoma and insulinoma tumour growth.
Reubi JC
Acta Endocrinol (Copenh); 1985 May; 109(1):108-14. PubMed ID: 2860768
[TBL] [Abstract][Full Text] [Related]
10. Remission of symptoms of chemotherapy-refractory metastatic insulinoma using octreotide.
Longnecker SM
Drug Intell Clin Pharm; 1988 Feb; 22(2):136-8. PubMed ID: 2894965
[TBL] [Abstract][Full Text] [Related]
11. Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995.
Boden G; Ryan IG; Eisenschmid BL; Shelmet JJ; Owen OE
N Engl J Med; 1986 Jun; 314(26):1686-9. PubMed ID: 2872592
[No Abstract] [Full Text] [Related]
12. Rapid reversal of life-threatening hypoglycaemia with a somatostatin analogue (octreotide). A case report.
Alberts AS; Falkson G
S Afr Med J; 1988 Jul; 74(2):75-6. PubMed ID: 2899913
[TBL] [Abstract][Full Text] [Related]
13. Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995).
Kvols LK; Buck M; Moertel CG; Schutt AJ; Rubin J; O'Connell MJ; Hahn RG
Ann Intern Med; 1987 Aug; 107(2):162-8. PubMed ID: 2886085
[TBL] [Abstract][Full Text] [Related]
14. Chronic treatment of a benign insulinoma using the long-acting somatostatin analogue SMS 201-995.
Glaser B; Rösler A; Halperin Y
Isr J Med Sci; 1990 Jan; 26(1):16-9. PubMed ID: 2155884
[TBL] [Abstract][Full Text] [Related]
15. Octreotide: Jack-of-all-trades or expensive orphan?
Offerhaus L
Neth J Med; 1988 Jun; 32(5-6):265-9. PubMed ID: 2899297
[No Abstract] [Full Text] [Related]
16. The use of SMS 201-995 (somatostatin analogue) in insulinomas. Additional case report and literature review.
Hearn PR; Ahmed M; Woodhouse NJ
Horm Res; 1988; 29(5-6):211-3. PubMed ID: 2851522
[TBL] [Abstract][Full Text] [Related]
17. [Successful therapy of VIPoma with the long-acting somatostatin analogue SMS 201-995].
Maeda M; Niitsu Y; Goto Y; Kogawa K; Watanabe N; Kohgo Y; Urushizaki I
Nihon Naika Gakkai Zasshi; 1988 Jan; 77(1):86-90. PubMed ID: 2897419
[No Abstract] [Full Text] [Related]
18. Suppression of primary and secondary peptides with somatostatin analog in the therapy of functional endocrine tumors.
Woltering EA; Mozell EJ; O'Dorisio TM; Fletcher WS; Howe B
Surg Gynecol Obstet; 1988 Dec; 167(6):453-62. PubMed ID: 2460958
[TBL] [Abstract][Full Text] [Related]
19. Perioperative use of long-acting somatostatin analog (SMS 201-995) in patients with endocrine tumors of the gastroenteropancreatic axis.
Tsai ST; Eckhauser FE; Thompson NW; Strodel WE; Vinik AI
Surgery; 1986 Oct; 100(4):788-95. PubMed ID: 2876529
[TBL] [Abstract][Full Text] [Related]
20. [Attempt in treating benign insulinoma by delayed somatostatin. 2 cases].
Picq R; Vialettes B; de la Tour d'Auvergne M; Joliot AY; Vague P
Presse Med; 1988 Nov; 17(39):2087. PubMed ID: 2849769
[No Abstract] [Full Text] [Related]
[Next] [New Search]
